The drugmaker said it agreed to pay RAPT Therapeutics shareholders $58 per share, with $1.9 billion upfront investment in cash.
Source link
GSK to Acquire RAPT for $2.2 Billion to Bolster Food Allergy Treatments
Date:
More like thisRelated
Catholic Diocese of Las Cruces gets more support from border communities in fight over Mount Cristo Rey property
EL PASO, Texas (KTSM) – A federal judge in...
Nike Names Pfizer’s Denton as Next CFO
David Denton’s appointment, effective Aug. 17, comes as the...
USMNT faces World Cup dilemma vs. Turkiye: Rotate squad or keep same XI?
SEATTLE -- It's a position that the U.S. men's...
Rubio arrives in UAE with aim to head off Gulf Arab unease over tentative Iran deal
ABU DHABI, United Arab Emirates -- U.S. Secretary of...